Strategic Pricing and Market Access for 505(b)(2) Therapeutics: A Framework for Optimal Launch
In the rapidly evolving landscape of pharmaceutical innovation, the launch of 505(b)(2) therapeutics presents both unprecedented opportunities and complex challenges. As the industry shifts toward more personalized, targeted treatments, the strategic a…
